What to compare before switching Before switching GLP-1 drugs, separate the real trigger, plateau, nausea, access problems, or inadequate appetite control, from behavior drift like lower protein intake or missed doses
Neuroketotherapeutics: a modern review of a century-old therapy

IL-22 has been reported to promote epithelial cell proliferation and induce the production of Reg3 and other antimicrobial peptides ( + T cells are the main cell types that secrete IL-22 in the gut ( + T cells and subsequent production of IL-22 through several mechanisms ( Monocytes and macrophages Toll-like receptors (TLRs) recognize different pathogen-associated molecular patterns and trigger the production of pro-inflammatory factors in macrophages ( Staphylococcus aureus -induced mastitis model, intake of high-dose inulin was shown to inhibit HDAC3 by promoting butyrate production in mice, thereby activating the macrophage-mediated antimicrobial defense program ( - monocytes, and enhanced alternative macrophage activation, thereby inhibiting CXCL1 production, neutrophil recruitment, and the immune response during infection ( Regulation of inulin and its metabolites of energy metabolism DF can slow down the absorption of glucose as well as impede the uptake of dietary lipids and cholesterol to enhance satiety and improve insulin resistance

In contrast, pretreatment with exendin-(939) (a GLP-1R antagonist) completely antagonized the antioxidant effect of exendin-4 ( Figures 1B, C , respectively)
Statistical analysis GraphPad Prism 7.0 was used for all analyses
The opioid hypothesis is best described as an interpretation that guided a research programme, not a finding that programme established